Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
UK: Funding cuts for drug and alcohol treatment

Earlier this month (October 2014) Public Health England and the Association of Directors of Public Health published a joint review of drug and alcohol commissioning in England and Wales. This Department of Health funded review was based on a series of interviews with Directors of Public Health (94% of the 152 Upper Tier authorities participated) and Drugscope and looked at current and future commissioning plans for drug and alcohol treatment.

Published
17 October 2014
From
Russell Webster (blog)
Africa: Writing the Final Chapter on AIDS

The 90-90-90 plan, unveiled by the Joint United Nations Programme on HIV/AIDS (UNAIDS) earlier this year, seeks to halt the spread of HIV by 2020 and to end the epidemic by 2030. Some African countries are on track to achieving the ambitious 90-90-90 targets.

Published
17 October 2014
From
Inter Press Service
High effectiveness seen in English PrEP trial

The Steering Committee* of the PROUD trial of pre-exposure prophylaxis (PrEP) in gay men in England announced today that participants currently on the deferred arm of the

Published
16 October 2014
By
Gus Cairns
IDWeek 2014: Behavioral and Financial Incentives May Improve HIV Treatment Outcomes

While making medications free can remove barriers to access for individuals who cannot pay for treatment, data suggest that for most people accessing care in industrialized countries, "making medications available for free or low cost will not solve problems with medication non-adherence," according to a presentation by Kevin Volpp from the University of Pennsylvania last week at IDWeek 2014 in Philadelphia.

Published
16 October 2014
From
HIVandHepatitis.com
Targeted adherence measures and viral load monitoring needed to improve retention in South African ART programme

Of the people living with HIV in South Africa who are eligible to start antiretroviral therapy (ART), only 57% are in care and only 37% of

Published
16 October 2014
By
Lesley Odendal
Inventing the end of AIDS is premature and dangerous

In recent years, I have had many misgivings about the state of the AIDS response. I have watched with growing disquiet as the Joint United Nations Programme on HIV/AIDS (UNAIDS) has published its global report on the state of AIDS each year, increasingly taking on the voice of a cheerleader, applauding country efforts, commending progress and being the bearer of good news.

Published
15 October 2014
From
International HIV / AIDS Alliance
Unique 'pay if you clear' proposal for new hepatitis drug

The NHS in Scotland could be reimbursed for the cost of a new hepatitis drug if sufferers fail to clear the virus. The novel proposal was revealed after the drug Olysio was cleared for use by the Scottish Medicines Consortium (SMC).

Published
15 October 2014
From
BBC
Fair Pricing Coalition Urges a Uniform Price for Curative Hepatitis C Treatment

The $63,000 wholesale acquisition cost (WAC) for eight weeks of Harvoni™ (sofosbuvir and ledipasvir) should be extended to 12 and 24-week curative treatment durations.

Published
15 October 2014
From
Fair Pricing Coalition
If AbbVie Discounts its Hep C Drug, Would Pricing Reach a Tipping Point?

Now that the FDA has approved the Harvoni treatment from Gilead Sciences and a $94,500 price for a 12-week regimen has been established, attention is turning toward AbbVie and the steps the big drug maker must take to win market share. Already, though, some Wall Street prognosticators believe AbbVie may find it daunting.

Published
15 October 2014
From
Wall Street Journal
Care programme improves clinic attendance and rates of virologic suppression among vulnerable HIV-positive patients in New York

Enrolment in a comprehensive care co-ordination programme significantly improves levels of engagement with HIV care and virologic suppression in vulnerable HIV-positive adults, according to research published in the

Published
14 October 2014
By
Michael Carter

Filter by country